Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejection-Reference-Cited by-同舟云学术

Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejection

Published:2024-04-16 Issue:5 Volume:39 Page:549-564
ISSN:0393-2990
Container-title:European Journal of Epidemiology
language:en
Short-container-title:Eur J Epidemiol

Author:

Goutaudier Valentin,Sablik Marta,Racapé Maud,Rousseau Olivia,Audry Benoit,Kamar Nassim,Raynaud Marc,Aubert Olivier,Charreau Béatrice,Papuchon Emmanuelle,Danger Richard,Letertre Laurence,Couzi Lionel,Morelon Emmanuel,Le Quintrec Moglie,Taupin Jean-Luc,Vicaut Eric,Legendre Christophe,Le Mai Hoa,Potluri Vishnu,Nguyen Thi-Van-Ha,Azoury Marie-Eliane,Pinheiro Alice,Nouadje Georges,Sonigo Pierre,Anglicheau Dany,Tieken Ineke,Vogelaar Serge,Jacquelinet Christian,Reese Peter,Gourraud Pierre-Antoine,Brouard Sophie,Lefaucheur Carmen,Loupy Alexandre^ORCID,

Funder

Agence Nationale de la Recherche

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10654-024-01112-w.pdf

Reference56 articles.

1. Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF. Review of the clinical and economic burden of antibody-mediated rejection in renal transplant recipients. Adv Ther. 2016;33(3):345–56. https://doi.org/10.1007/s12325-016-0292-y.

2. Loupy A, Mengel M, Haas M. Thirty years of the international banff classification for allograft pathology: the past, present, and future of kidney transplant diagnostics. Kidney Int. 2022;101(4):678–91. https://doi.org/10.1016/j.kint.2021.11.028.

3. Danger R, Le Berre L, Cadoux M, et al. Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression. Kidney Int. 2023;103(6):1167–79. https://doi.org/10.1016/j.kint.2023.03.019.

4. Lubetzky ML, Salinas T, Schwartz JE, Suthanthiran M. Urinary cell mRNA profiles predictive of human kidney allograft status. Clin J Am Soc Nephrol. 2021;16(10):1565–77. https://doi.org/10.2215/CJN.14010820.

5. Rabant M, Amrouche L, Lebreton X, et al. Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody–mediated kidney allograft rejection. J Am Soc Nephrol. 2015;26(11):2840–51. https://doi.org/10.1681/ASN.2014080797.